ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF
The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | QUIGLEY, Anna, Maria, Matilda DOYLE, Anthony, Gerard POULTON, Lynn POLLARD, Matthew BRACKEN, Anna, Mikaela CLARKE, Adam LIDDAMENT, Mark, Terence COOKSEY, Bridget, A SZABAT, Marta ROZENFELD, Julia |
description | The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4200018B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4200018B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4200018B13</originalsourceid><addsrcrecordid>eNrjZDBw9Avx1A1wDNI1UgAxnfxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBiZGBgYGjhZGhMhBIAqu0lUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><source>esp@cenet</source><creator>QUIGLEY, Anna, Maria, Matilda ; DOYLE, Anthony, Gerard ; POULTON, Lynn ; POLLARD, Matthew ; BRACKEN, Anna, Mikaela ; CLARKE, Adam ; LIDDAMENT, Mark, Terence ; COOKSEY, Bridget, A ; SZABAT, Marta ; ROZENFELD, Julia</creator><creatorcontrib>QUIGLEY, Anna, Maria, Matilda ; DOYLE, Anthony, Gerard ; POULTON, Lynn ; POLLARD, Matthew ; BRACKEN, Anna, Mikaela ; CLARKE, Adam ; LIDDAMENT, Mark, Terence ; COOKSEY, Bridget, A ; SZABAT, Marta ; ROZENFELD, Julia</creatorcontrib><description>The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2025</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20250101&DB=EPODOC&CC=EP&NR=4200018B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20250101&DB=EPODOC&CC=EP&NR=4200018B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QUIGLEY, Anna, Maria, Matilda</creatorcontrib><creatorcontrib>DOYLE, Anthony, Gerard</creatorcontrib><creatorcontrib>POULTON, Lynn</creatorcontrib><creatorcontrib>POLLARD, Matthew</creatorcontrib><creatorcontrib>BRACKEN, Anna, Mikaela</creatorcontrib><creatorcontrib>CLARKE, Adam</creatorcontrib><creatorcontrib>LIDDAMENT, Mark, Terence</creatorcontrib><creatorcontrib>COOKSEY, Bridget, A</creatorcontrib><creatorcontrib>SZABAT, Marta</creatorcontrib><creatorcontrib>ROZENFELD, Julia</creatorcontrib><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><description>The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2025</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9Avx1A1wDNI1UgAxnfxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g4OYa4uyhm1qQH59aXJCYnJqXWhLvGmBiZGBgYGjhZGhMhBIAqu0lUg</recordid><startdate>20250101</startdate><enddate>20250101</enddate><creator>QUIGLEY, Anna, Maria, Matilda</creator><creator>DOYLE, Anthony, Gerard</creator><creator>POULTON, Lynn</creator><creator>POLLARD, Matthew</creator><creator>BRACKEN, Anna, Mikaela</creator><creator>CLARKE, Adam</creator><creator>LIDDAMENT, Mark, Terence</creator><creator>COOKSEY, Bridget, A</creator><creator>SZABAT, Marta</creator><creator>ROZENFELD, Julia</creator><scope>EVB</scope></search><sort><creationdate>20250101</creationdate><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><author>QUIGLEY, Anna, Maria, Matilda ; DOYLE, Anthony, Gerard ; POULTON, Lynn ; POLLARD, Matthew ; BRACKEN, Anna, Mikaela ; CLARKE, Adam ; LIDDAMENT, Mark, Terence ; COOKSEY, Bridget, A ; SZABAT, Marta ; ROZENFELD, Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4200018B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2025</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>QUIGLEY, Anna, Maria, Matilda</creatorcontrib><creatorcontrib>DOYLE, Anthony, Gerard</creatorcontrib><creatorcontrib>POULTON, Lynn</creatorcontrib><creatorcontrib>POLLARD, Matthew</creatorcontrib><creatorcontrib>BRACKEN, Anna, Mikaela</creatorcontrib><creatorcontrib>CLARKE, Adam</creatorcontrib><creatorcontrib>LIDDAMENT, Mark, Terence</creatorcontrib><creatorcontrib>COOKSEY, Bridget, A</creatorcontrib><creatorcontrib>SZABAT, Marta</creatorcontrib><creatorcontrib>ROZENFELD, Julia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QUIGLEY, Anna, Maria, Matilda</au><au>DOYLE, Anthony, Gerard</au><au>POULTON, Lynn</au><au>POLLARD, Matthew</au><au>BRACKEN, Anna, Mikaela</au><au>CLARKE, Adam</au><au>LIDDAMENT, Mark, Terence</au><au>COOKSEY, Bridget, A</au><au>SZABAT, Marta</au><au>ROZENFELD, Julia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF</title><date>2025-01-01</date><risdate>2025</risdate><abstract>The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human PAR-2 and compositions comprising such antibodies or antigen-binding fragments thereof. In a particular aspect, the antibodies or antigen-binding fragments thereof that specifically bind to human PAR-2 block the interaction between a PAR-2 activating ligand and an extracellular domain of PAR-2, and/or blocks PAR-2 activation by a PAR-2 activating ligand, In further aspects, the antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased expression of PAR-2 and/or diseases or conditions that can be alleviated by antagonizing activation of PAR-2 by a PAR-2 activating ligand (e.g., airway diseases, skin diseases, cancer, orofacial granulomatosis, inflammatory conditions, and pain associated with various diseases or conditions).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP4200018B1 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T23%3A11%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QUIGLEY,%20Anna,%20Maria,%20Matilda&rft.date=2025-01-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4200018B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |